Download PDF
Aktuelle Ernährungsmedizin 2007; 32: S124-S133
DOI: 10.1055/s-2006-951899
Leitlinie Parenterale Ernährung der DGEM
© Georg Thieme Verlag KG Stuttgart · New York

19 Nichtchirurgische Onkologie

J.  Arends (gemeinsamer AG-Leiter), G.  Zürcher (gemeinsamer AG-Leiter), A.  Dossett, R.  Fietkau, M.  J.  Hug, I.  Schmid, E.  Shang, A.  R.  Zander
Further Information

Publication History

Publication Date:
04 March 2008 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

Tumor - Radiotherapie - Chemotherapie - Stammzelltransplantation

Key words

tumour - radiotherapy - chemotherapy - stem cell transplantation

Literatur

  • 1 Tubiana M, Attié E, Flamant R, Gérard-Marchant R, Hayat M. Prognostic factors in 454 cases of Hodgkin's Disease.  Cancer Res. 1971;  31 1801-1810
    PubMedGoogle Scholar
  • 2 Swenerton K D, Legha S S, Smith T. et al . Prognostic factors in metastatic breast cancer treated with combination chemotherapy.  Cancer Res. 1979;  39 1552-1562
    PubMedGoogle Scholar
  • 3 DeWys W D, Begg C, Lavin P T. et al . Prognostic effect of weight loss prior to chemotherapy in cancer patients.  Am J Med. 1980;  69 491-497
    PubMedGoogle Scholar
  • 4 Eys J van. Effect of nutritional status on response to therapy.  Cancer Res. 1982;  42 747-753
    PubMedGoogle Scholar
  • 5 Pedersen H, Hansen H S, Cederqvist C, Lober J. The prognostic significance of weight loss and its integration in stage-grouping of oesophageal cancer.  Acta Chir Scand. 1982;  148 363-366
    PubMedGoogle Scholar
  • 6 Bruning P F, Egger R J, Gooskens A C. et al . Dietary intake, nutritional status and well-being of cancer patients: a prospective study.  Eur J Cancer. 1985;  21 1449-1459
    PubMedGoogle Scholar
  • 7 Padilla G V. Psychological aspects of nutrition and cancer.  Surg Clin North Am. 1986;  66 1121-1135
    PubMedGoogle Scholar
  • 8 Andreyev H JN, Norman A R, Oates J, Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?.  Eur J Cancer. 1998;  34 503-509
    CrossrefPubMedGoogle Scholar
  • 9 Argiris A, Li Y, Forastiere A. Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck.  Cancer. 2004;  101 2222-2229
    CrossrefPubMedGoogle Scholar
  • 10 Ravasco P, Monteiro-Grillo I, Vidal P M, Camilo M E. Cancer: disease and nutrition are key determinants of patients' quality of life.  Supp Care Cancer. 2004;  12 246-252
    CrossrefPubMedGoogle Scholar
  • 11 Ross P J, Ashley S, Norton A. et al . Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?.  British Journal of Cancer. 2004;  90 1905-1911
    CrossrefPubMedGoogle Scholar
  • 12 Warren S. The immediate causes of death in cancer.  Am J Med Sci. 1932;  184 610-615
    PubMedGoogle Scholar
  • 13 Aslani A, Smith R C, Allen B J, Paviakis N, Levi J A. The predictive value of body protein for chemotherapy-induced toxicity.  Cancer. 2000;  88 796-803
    CrossrefPubMedGoogle Scholar
  • 14 Donaldson S S, Wesley M N. A study of the nutritional status of pediatric cancer patients.  Am J Dis Child. 1981;  135 1107-1112
    PubMedGoogle Scholar
  • 15 Rickard K A, Detamore C M, Coates T D. et al . Effect of nutrition staging on treatment delays and outcome in Stage IV neuroblastoma.  Cancer. 1983;  52 587-598
    CrossrefPubMedGoogle Scholar
  • 16 Lobato-Mendizabal E, Ruiz-Arguelles G J, Marin-Lopez A. Leukaemia and nutrition. I: Malnutrition is an adverse prognostic factor in the outcome of treatment of patients with standard-risk acute lymphoblastic leukaemia.  Leuk Res. 1989;  13 899-906
    PubMedGoogle Scholar
  • 17 Viana M B, Murao M, Ramos G. et al . Malnutrition as a prognostic factor in lymphoblastic leukaemia: a multivariate analysis.  Arch Dis Child. 1994;  71 304-310
    PubMedGoogle Scholar
  • 18 Mejia-Arangure J M, Fajardo-Gutierrez A, Reyes-Ruiz N I. et al . Malnutrition in childhood lymphoblastic leukemia: a predictor of early mortality during the induction-to-remission phase of the treatment.  Arch Med Res. 1999;  30 150-153
    CrossrefPubMedGoogle Scholar
  • 19 Weir J, Reilly J J, McColl J H, Gibson B E. No evidence for an effect of nutritional status at diagnosis on prognosis in children with acute lymphoblastic leukemia.  J Pediatr Hematol Oncol. 1998;  20 534-538
    CrossrefPubMedGoogle Scholar
  • 20 Pedrosa F, Bonilla M, Liu A. et al . Effect of malnutrition at the time of diagnosis on the survival of children treated for cancer in El Salvador and Northern Brazil.  J Pediatr Hematol Oncol. 2000;  22 502-505
    PubMedGoogle Scholar
  • 21 Wessels G HP. Nutrition, morbidity and survival in South African children with Wilms tumor.  J Pediatr Hematol Oncol. 1999;  16 321-327
    CrossrefPubMedGoogle Scholar
  • 22 Yaris N, Akyuz C, Coskun T, Kutluk T, Buyukpamukcu M. Nutritional status of children with cancer and its effects on survival.  Turk J Pediatr. 2002;  44 35-39
    PubMedGoogle Scholar
  • 23 Rickard K A, Grosfeld J L, Kirksey A, Ballantine T V, Baehner R L. Reversal of protein-energy malnutrition in children during treatment of advanced neoplastic disease.  Ann Surg. 1979;  190 771-781
    PubMedGoogle Scholar
  • 24 Picton S V. Aspects of altered metabolism in children with cancer.  Int J Cancer Suppl. 1998;  11 62-64
    PubMedGoogle Scholar
  • 25 Halton J M, Scissons-Fisher C C. Impact of nutritional status on morbidity and dose intensity of chemotherapy during consolidation therapy in children with acute lymphoblastic leukaemia.  J Pediatr Hematol Oncol. 1999;  21 317
    PubMedGoogle Scholar
  • 26 Hughes W T, Price R A, Sisko F. et al . Protein-calorie malnutrition. A host determinant for Pneumocystis carinii infection.  Am J Dis Child. 1974;  128 44-52
    PubMedGoogle Scholar
  • 27 Taj M M, Pearson A D, Mumford D B, Price L. Effect of nutritional status on the incidence of infection in childhood cancer.  Pediatr Hematol Oncol. 1993;  10 283-287
    PubMedGoogle Scholar
  • 28 Obama M, Cangir A, Eys J van. Nutritional status and anthracycline cardiotoxicity in children.  South Med J. 1983;  76 577-578
    PubMedGoogle Scholar
  • 29 Bosaeus I, Daneryd P, Svanberg E, Lundholm K. Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients.  Int J Cancer. 2001;  93 380-383
    CrossrefPubMedGoogle Scholar
  • 30 Knox L S, Crosby L O, Feurer I D, Buzby G P, Miller C L, Mullen J L. Energy expenditure in malnourished cancer patients.  Ann Surg. 1983;  197 152-161
    CrossrefPubMedGoogle Scholar
  • 31 Dempsey D T, Feurer I D, Knox L S, Crosby L O, Buzby G P, Mullen J L. Energy expenditure in malnourished gastrointestinal cancer patients.  Cancer. 1984;  53 1265-1273
    CrossrefPubMedGoogle Scholar
  • 32 Dempsey D T, Knox L S, Mullen J L, Miller C L, Feurer I D, Buzby G P. Energy expenditure in malnourished patients with colorectal cancer.  Arch Surg. 1986;  121 789-795
    CrossrefPubMedGoogle Scholar
  • 33 Hansell D T, Davies J W, Burns H J. Effects of hepatic metastases on resting energy expenditure in patients with colorectal cancer.  Br J Surg. 1986;  73 659-662
    CrossrefPubMedGoogle Scholar
  • 34 Fredrix E W, Soeters P B, Wouters E F, Deerenberg I M, Meyenfeldt M F von, Saris W H. Effect of different tumor types on resting energy expenditure.  Cancer Res. 1991;  51 6138-6141
    PubMedGoogle Scholar
  • 35 Gibney E, Elia M, Jebb S A, Murgatroyd P, Jennings G. Total energy expenditure in patients with small-cell lung cancer: results of a validated study using the bicarbonate-urea method.  Metabolism. 1997;  46 1412-1417
    CrossrefPubMedGoogle Scholar
  • 36 Moses A W, Slater C, Preston T, Barber M D, Fearon K C. Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids.  Br J Cancer. 2004;  90 996-1002
    CrossrefPubMedGoogle Scholar
  • 37 Kien C L, Camitta B M. Close association of accelerated rates of whole body protein turnover (synthesis and breakdown) and energy expenditure in children with newly diagnosed acute lymphocytic leukemia.  JPEN J Parenter Enteral Nutr. 1987;  11 129-134
    PubMedGoogle Scholar
  • 38 Stallings V A, Vaisman N, Chan H S, Weitzman S S, Hahn E, Pencharz P B. Energy metabolism in children with newly diagnosed acute lymphoblastic leukemia.  Pediatr Res. 1989;  26 154-157
    CrossrefPubMedGoogle Scholar
  • 39 Bond S A, Han A M, Wootton S A, Kohler J A. Energy intake and basal metabolic rate during maintenance chemotherapy.  Arch Dis Child. 1992;  67 229-232
    PubMedGoogle Scholar
  • 40 Vaisman N, Stallings V A, Chan H, Weitzman S S, Clarke R, Pencharz P B. Effect of chemotherapy on the energy and protein metabolism of children near the end of treatment for acute lymphoblastic leukemia.  Am J Clin Nutr. 1993;  57 679-684
    PubMedGoogle Scholar
  • 41 Broeder E den, Oeseburg B, Lippens R J. et al . Basal metabolic rate in children with a solid tumour.  Eur J Clin Nutr. 2001;  55 673-681
    CrossrefPubMedGoogle Scholar
  • 42 Moldawer L L, Copeland E M. Proinflammatory cytokines, nutritional support, and the cachexia syndrom.  Cancer. 1997;  79 1828-1839
    CrossrefPubMedGoogle Scholar
  • 43 Blaauw I de, Deutz N EP, Meyenfeldt M F von. Metabolic changes in cancer cachexia - first of two parts.  Clin Nutr. 1997;  16 169-176
    PubMedGoogle Scholar
  • 44 Blaauw I de, Deutz N EP, Meyenfeldt M F von. Metabolic changes of cancer cachexia - second of two parts.  Clin Nutr. 1997;  16 223-228
    PubMedGoogle Scholar
  • 45 Inui A. Cancer anorexia-cachexia syndrome: Are neuropeptides the key?.  Cancer Res. 1999;  59 4493-4501
    PubMedGoogle Scholar
  • 46 Ramos E J, Suzuki S, Marks D, Inui A, Asakawa A, Meguid M M. Cancer anorexia-cachexia syndrome: cytokines and neuropeptides.  Curr Opin Clin Nutr Metab Care. 2004;  7 427-434
    CrossrefPubMedGoogle Scholar
  • 47 Fearon K CH, Barber M D, Falconer J S, McMillan D C, Ross J A, Preston T. Pancreatic cancer as a model: Inflammatory mediators, acute-phase response, and cancer cachexia.  World J Surg. 1999;  23 584-588
    PubMedGoogle Scholar
  • 48 Fordy C, Glover C, Henderson D C, Summerbell C, Wharton R, Allen-Mersh T G. Contribution of diet, tumour volume and patient-related factors to weight loss in patients with colorectal liver metastases.  Br J Surg. 1999;  86 639-644
    CrossrefPubMedGoogle Scholar
  • 49 Simons J PFHA, Schols A M, Buurman W A, Wouters E F. Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones.  Clin Sci. 1999;  97 215-223
    PubMedGoogle Scholar
  • 50 Meyenfeldt M F von. Nutritional support during treatment of biliopancreatic malignancy.  Ann Oncol. 1999;  10 273-277
    CrossrefPubMedGoogle Scholar
  • 51 Espat N J, Moldawer L L, Copeland E M. Cytokine-mediated alterations in host metabolism prevent nutritional repletion in cachectic cancer patients.  J Surg Oncol. 1995;  58 77-82
    PubMedGoogle Scholar
  • 52 Martin F, Santolaria F, Batista N. et al . Cytokine levels (IL-6 and IFN-gamma), acute phase response and nutritional status as prognostic factors in lung cancer.  Cytokine. 1999;  11 80-86
    CrossrefPubMedGoogle Scholar
  • 53 O'Gorman P, McMillan D C, McArdle C S. Prognostic factors in advanced gastrointestinal cancer patients with weight loss.  Nutr Cancer. 2000;  37 36-40
    PubMedGoogle Scholar
  • 54 Lundholm K, Holm G, Schersten T. Insulin resistance in patients with cancer.  Cancer Res. 1978;  38 4665-4670
    PubMedGoogle Scholar
  • 55 Starnes H F, Warren R S, Brennan M F. Protein synthesis in hepatocytes isolated from patients with gastrointestinal malignancy.  J Clin Invest. 2002;  80 1384-1390
    PubMedGoogle Scholar
  • 56 Shaw J HF, Wolfe R R. Fatty acid and glycerol kinetics in septic patients and in patients with gastrointestinal cancer.  Ann Surg. 1997;  205 368-376
    PubMedGoogle Scholar
  • 57 Zuijdgeest-van Leeuwen S D, Berg J WO van den, Wattimena J LD. et al . Lipolysis and lipid oxidation in weight-losing cancer patients and healthy subjects.  Metabolism. 2000;  49 931-936
    CrossrefPubMedGoogle Scholar
  • 58 Körber J, Pricelius S, Heidrich M, Müller M J. Increased lipid utilization in weight losing and weight stable cancer patients with normal body weight.  Eur J Clin Nutr. 1999;  53 740-745
    CrossrefPubMedGoogle Scholar
  • 59 Barber M D, McMillan D C, Preston T, Ross J A, Fearon K CH. Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supllement.  Clin Sci. 2000;  98 389-399
    PubMedGoogle Scholar
  • 60 Legaspi A, Jeevanandam M, Starnes Jr H F, Brennan M F. Whole body lipid and energy metabolism in the cancer patient.  Metabolism. 1987;  36 958-963
    CrossrefPubMedGoogle Scholar
  • 61 Jeevanandam M, Horowitz G D, Lowry S F, Brennan M F. Cancer cachexia and protein metabolism.  Lancet. 1984;  1 1424-1426
    PubMedGoogle Scholar
  • 62 Williams A, Sun X, Fischer J F, Hasselgren P O. The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer.  Surgery. 1999;  126 744-750
    CrossrefPubMedGoogle Scholar
  • 63 Bossola M, Muscaritoli M, Costelli P. et al . Increased muscle ubiquitin mRNA levels in gastric cancer patients.  Am J Physiol Regulatory Integrative Comp Phsyiol. 2001;  280 R1518-R1523
    PubMedGoogle Scholar
  • 64 Tisdale M J. The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting.  The Journal of Supportive Oncology. 2005;  3 209-217
    PubMedGoogle Scholar
  • 65 Tisdale M J. Protein loss in cancer cachexia.  Science. 2000;  289 2293
    CrossrefPubMedGoogle Scholar
  • 66 Cabal-Manzano R, Bhargava P, Torres-Duarte A, Marshall J, Bhargava P, Wainer I W. Proteolysis-inducing factor is expressed in tumours of patients with gastrointestinal cancers and correlates with weight loss.  British Journal of Cancer. 2001;  84 1599-1601
    CrossrefPubMedGoogle Scholar
  • 67 Scolapio J S, Ukleja A, Burnes J U, Kelly D G. Outcome of patients with radiation enteritis treated with home parenteral nutrition.  American Journal of Gastroenterology. 2002;  97 662-666
    CrossrefPubMedGoogle Scholar
  • 68 Hyltander A, Drott C, Unsgaard B. et al . The effect on body composition and exercise performance of home parenteral nutrition when given as adjunct to chemotherapy of testicular carcinoma.  Eur J Clin Invest. 1991;  21 413-420
    PubMedGoogle Scholar
  • 69 Cozzaglio L, Balzola F, Cosentino F. et al . Outcome of cancer patients receiving home parenteral nutrition.  JPEN J Parenter Enteral Nutr. 1997;  21 339-342
    CrossrefPubMedGoogle Scholar
  • 70 Meuret G, Springer J. Parenterale Heimernährung bei fortgeschrittenen Tumorkrankheiten.  Akt Ernährungsmed. 1999;  24 270-276
    PubMedGoogle Scholar
  • 71 Bozzetti F, Cozzaglio L, Biganzoli E. et al . Quality of life and length of survival in advanced cancer patients on home parenteral nutrition.  Clin Nutr. 2002;  21 281-288
    CrossrefPubMedGoogle Scholar
  • 72 Fearon K CH, Meyenfeldt M F von, Moses A G. et al . Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial.  Gut. 2003;  52 1479-1486
    CrossrefPubMedGoogle Scholar
  • 73 Howard L. Home parenteral nutrition in patients with a cancer diagnosis.  JPEN J Parenter Enteral Nutr. 1992;  16 93S-99S
    PubMedGoogle Scholar
  • 74 Pironi L, Ruggeri E, Tanneberger S, Giordani S, Pannuti F, Miglioli M. Home artificial nutrition in advanced cancer.  J R Soc Med. 1997;  90 597-603
    CrossrefPubMedGoogle Scholar
  • 75 Scolapio J S, Fleming C R, Kelly D G. Survival of home parenteral nutrition-treated patients: 20 years of experience at the Mayo Clinic.  May Clin Proc. 1999;  74 217-222
    CrossrefPubMedGoogle Scholar
  • 76 Duerksen D R, Ting E, Thomson P. et al . Is there a role for TPN in terminally ill patients with bowel obstruction?.  Nutrition. 2004;  20 760-763
    CrossrefPubMedGoogle Scholar
  • 77 Moreno Vilares J M, Gomis Munoz P, Valero Zanuy M A, Leon Sanz M. Home parenteral nutrition in patients with advanced cancer: experience of a single centre over ten years.  Nutr Hosp. 2004;  19 253-258
    PubMedGoogle Scholar
  • 78 Hoda D, Jatoi A, Burnes J, Loprinzi C, Kelly D. Should patients with advanced, incurable cancers ever be sent home with total parenteral nutrition? A single institution's 20-year experience.  Cancer. 2005;  103 863-868
    CrossrefPubMedGoogle Scholar
  • 79 Orrevall Y, Tishelman C, Herrington M K, Permert J. The path from oral nutrition to home parenteral nutrition: a qualitative interview study of the experiences of advanced cancer patients and their families.  Clin Nutr. 2004;  23 1280-1287
    PubMedGoogle Scholar
  • 80 Braunschweig C, Liang H F, Sheean P. Indications for administration of parenteral nutrition in adults.  Nutr Clin Pract. 2004;  19 255-262
    PubMedGoogle Scholar
  • 81 Klein S, Koretz R L. Nutrition support in patients with cancer: What do the data really show?.  Nutr Clin Pract. 1994;  9 91-100
    CrossrefPubMedGoogle Scholar
  • 82 Ollenschläger G, Konkol K, Mödder B. Indications for and results of nutritional therapy in cancer patients.  Rec Res Cancer Res. 1988;  108 172-184
    PubMedGoogle Scholar
  • 83 Sax H C, Souba W W. Enteral and parenteral feedings. Guidelines and recommendations.  Med Clin North Am. 1993;  77 863-880
    PubMedGoogle Scholar
  • 84 Hackl J M, Balogh D. Indikation zur künstlichen Ernährung - was ist gesichert?.  Akt Ernährungsmed. 1997;  22 146-153
    PubMedGoogle Scholar
  • 85 Koretz R L, Lipman T O, Klein S. American Gastroenterological Association . AGA technical review on parenteral nutrition.  Gastroenterology. 2001;  121 970-1001
    PubMedGoogle Scholar
  • 86 ASPEN Board of Directors and the Clinical Guidelines Task Force . Indications for specialized nutrition support.  JPEN J Parenter Enteral Nutr. 2002;  26 18SA-20SA
    PubMedGoogle Scholar
  • 87 Bozzetti F. Home total parenteral nutrition in incurable cancer patients: a therapy, a basic humane care or something in between?.  Clin Nutr. 2003;  22 109-111
    CrossrefPubMedGoogle Scholar
  • 88 Druml W, Jadrna K, Roth E. Empfehlungen für die enterale und parenterale Ernährungstherapie des Erwachsenen. Wien; Arbeitsgemeinschaft für klinische Ernährung (AKE) 2004
    Google Scholar
  • 89 Brennan M F, Ekman L. Metabolic consequences of nutritional support of the cancer patient.  Cancer. 1984;  54 2627-2634
    CrossrefPubMedGoogle Scholar
  • 90 Bozzetti F, Gavazzi C, Ferrari P, Dworzak F. Effect of total parenteral nutrition on the protein kinetics of patients with cancer cachexia.  Tumori. 2000;  86 408-411
    PubMedGoogle Scholar
  • 91 Bozzetti F, Bozzetti V. Efficacy of enteral and parenteral nutrition in cancer patients.  Nestle Nutr Workshop Ser Clin Perform Programme. 2005;  10 127-139
    PubMedGoogle Scholar
  • 92 Baron P L, Lawrence Jr W, Chan W M, White F K, Banks Jr W L. Effects of parenteral nutrition on cell cycle kinetics of head and neck cancer.  Arch Surg. 1986;  121 1282-1286
    PubMedGoogle Scholar
  • 93 Heys S D, Park K G, McNurlan M A. et al . Stimulation of protein synthesis in human tumours by parenteral nutrition: evidence for modulation of tumour growth.  Br J Surg. 1991;  78 483-487
    CrossrefPubMedGoogle Scholar
  • 94 Cao W X, Xiao H B, Yin H R. Effects of preoperative parenteral nutritional support with chemotherapy on tumor cell kinetics in gastric cancer patients.  Chung-Hua Chung Liu Tsa Chih [Chinese Journal of Oncology]. 1994;  16 137-140
    PubMedGoogle Scholar
  • 95 McNurlan M A, Heys S D, Park K G. et al . Tumour and host tissue responses to branched-chain amino acid supplementation of patients with cancer.  Clin Sci (Lond). 1994;  86 339-345
    PubMedGoogle Scholar
  • 96 Bozzetti F, Gavazzi C, Cozzaglio L, Costa A, Spinelli P, Viola G. Total parenteral nutrition and tumor growth in malnourished patients with gastric cancer.  Tumori. 1999;  85 163-166
    PubMedGoogle Scholar
  • 97 Jin D, Phillips M, Byles J E. Effects of parenteral nutrition support and chemotherapy on the phasic composition of tumor cells in gastrointestinal cancer.  JPEN J Parenter Enteral Nutr. 1999;  23 237-241
    PubMedGoogle Scholar
  • 98 Donaldson S S, Wesley M N, Ghavimi F, Shils M E, Suskind R M, DeWys W D. A prospective randomized clinical trial of total parenteral nutrition in children with cancer.  Med Pediatr Oncol. 1982;  10 129-139
    PubMedGoogle Scholar
  • 99 Rickard K A, Loghmani E S, Grosfeld J L. et al . Short- and long-term effectiveness of enteral and parenteral nutrition in reversing or preventing protein-energy malnutrition in advanced neuroblastoma. A prospective randomized study.  Cancer. 1985;  56 2881-2897
    PubMedGoogle Scholar
  • 100 Rickard K A, Godshall B J, Loghmani E S. et al . Integration of nutrition support into oncologic treatment protocols for high and low nutritional risk children with Wilms' tumor. A prospective randomized study.  Cancer. 1989;  64 491-509
    PubMedGoogle Scholar
  • 101 Eys J van, Copeland E M, Cangir A. et al . A clinical trial of hyperalimentation in children with metastatic malignancies.  Med Pediatr Oncol. 1980;  8 63-73
    PubMedGoogle Scholar
  • 102 Ghavimi F, Shils M E, Scott B F, Brown M, Tamaroff M. Comparison of morbidity in children requiring abdominal radiation and chemotherapy, with and without total parenteral nutrition.  J Pediatr. 1982;  101 530-537
    PubMedGoogle Scholar
  • 103 Hays D M, Merritt R J, White L, Ashley J, Siegel S E. Effect of total parenteral nutrition on marrow recovery during induction therapy for acute nonlymphocytic leukemia in childhood.  Med Pediatr Oncol. 1983;  11 134-140
    PubMedGoogle Scholar
  • 104 Shamberger R C, Pizzo P A, Goodgame Jr J T. et al . The effect of total parenteral nutrition on chemotherapy-induced myelosuppression. A randomized study.  Am J Med. 1983;  74 40-48
    PubMedGoogle Scholar
  • 105 IUCC Workshop . Nutritional morbidity in children with cancer: Mechanisms, measures and management.  Int J Cancer Suppl. 1998;  78 (Suppl II) 1-92
    PubMedGoogle Scholar
  • 106 Weisdorf S A, Lysne J, Wind D. et al . Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation.  Transplantation. 1987;  43 833-838
    PubMedGoogle Scholar
  • 107 Christensen M L, Hancock M L, Gattuso J. et al . Parenteral nutrition associated with increased infection rate in children with cancer.  Cancer. 1993;  72 2732-2738
    PubMedGoogle Scholar
  • 108 Bakish J, Hargrave D, Tariq N, Laperriere N, Rutka J T, Bouffet E. Evaluation of dietetic intervention in children with medulloblastoma or supratentorial primitive neuroectodermal tumors.  Cancer. 2003;  98 1014-1020
    CrossrefPubMedGoogle Scholar
  • 109 Nitenberg G, Raynard B. Nutritional support of the cancer patient: issues and dilemmas.  Crit Rev Oncol Hematol. 2000;  34 137-168
    CrossrefPubMedGoogle Scholar
  • 110 Holm E, Hagmuller E, Staedt U. et al . Substrate balances across colonic carcinomas in humans.  Cancer Res. 1995;  55 1373-1378
    PubMedGoogle Scholar
  • 111 Bozzetti F, Gavazzi C, Mariani L, Crippa F. Glucose-based total parenteral nutrition does not stimulate glucose uptake by humans tumours.  Clin Nutr. 2004;  23 417-421
    CrossrefPubMedGoogle Scholar
  • 112 Ulrich H, Pastores S M, Katz D P, Kvetan V. Parenteral use of medium-chain triglycerides: a reappraisal.  Nutrition. 1996;  12 231-238
    CrossrefPubMedGoogle Scholar
  • 113 Waitzberg D L, Lotierzo P H, Logullo A F, Torrinhas R S, Pereira C C, Meier R. Parenteral lipid emulsions and phagocytic systems.  Br J Nutr. 2002;  87, Suppl 1 S49-S57
    CrossrefPubMedGoogle Scholar
  • 114 Savarese D M, Savy G, Vahdat L, Wischmeyer P E, Corey B. Prevention of chemotherapy and radiation toxicity with glutamine.  Cancer Treat Rev. 2003;  29 501-513
    CrossrefPubMedGoogle Scholar
  • 115 Ziegler T R, Young L S, Benfell K. et al . Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study.  Ann Intern Med. 1992;  116 821-828
    CrossrefPubMedGoogle Scholar
  • 116 Schloerb P R, Amare M. Total parenteral nutrition with glutamine in bone marrow transplantation and other clinical applications (a randomized, double-blind study).  JPEN J Parenter Enteral Nutr. 1993;  17 407-413
    PubMedGoogle Scholar
  • 117 Schloerb P R, Skikne B S. Oral and parenteral glutamine in bone marrow transplantation: a randomized, double-blind study.  JPEN J Parenter Enteral Nutr. 1999;  23 117-122
    PubMedGoogle Scholar
  • 118 Ziegler T R, Bye R L, Persinger R L, Young L S, Antin J H, Wilmore D W. Effects of glutamine supplementation on circulating lymphocytes after bone marrow transplantation: a pilot study.  Am J Med Sci. 1998;  315 4-10
    CrossrefPubMedGoogle Scholar
  • 119 Pytlik R, Benes P, Patorkova M. et al . Standardized parenteral alanyl-glutamine dipeptide supplementation is not beneficial in autologous transplant patients: a randomized, double-blind, placebo controlled study.  Bone Marrow Transplant. 2002;  30 953-961
    CrossrefPubMedGoogle Scholar
  • 120 Brown S A, Goringe A, Fegan C. et al . Parenteral glutamine protects hepatic function during bone marrow transplantation.  Bone Marrow Transplant. 1998;  22 281-284
    CrossrefPubMedGoogle Scholar
  • 121 Zaanen H CT van, Lelie H van der, Timmer J G, Fürst P, Sauerwein H P. Parenteral glutamine dipeptide supplementation does not ameliorate chemotherapy-induced toxicity.  Cancer. 1994;  74 2879-2884
    CrossrefPubMedGoogle Scholar
  • 122 Scheid C, Hermann K, Kremer G. et al . Randomized, double-blind, controlled study of glycyl-glutamine-dipeptide in the parenteral nutrition of patients with acute leukemia undergoing intensive chemotherapy.  Nutrition. 2004;  20 249-254
    CrossrefPubMedGoogle Scholar
  • 123 ASPEN Board of Directors and the Clinical Guidelines Task Force . Specific guidelines for disease - adults: Cancer - hematopoetic cell transplantation.  JPEN J Parenter Enteral Nutr. 2002;  26 83SA-85SA
    PubMedGoogle Scholar
  • 124 Arfons L M, Lazarus H M. Total parenteral nutrition and hematopoietic stem cell transplantation: an expensive placebo?.  Bone Marrow Transplant. 2005;  36 281-288
    CrossrefPubMedGoogle Scholar
  • 125 Fietkau R. Principles of feeding cancer patients via enteral or parenteral nutrition during radiotherapy.  Strahlenther Onkol. 1998;  174, Suppl 3 47-51
    PubMedGoogle Scholar
  • 126 Body J J. Metabolic sequelae of cancers (excluding bone marrow transplantation).  Curr Opin Clin Nutr Metab Care. 1999;  2 339-344
    CrossrefPubMedGoogle Scholar
  • 127 Celaya P S, Valero Zanuy M A. Nutritional management of oncologic patients.  Nutr Hosp. 1999;  14, Suppl 2 43S-52S
    PubMedGoogle Scholar
  • 128 Schattner M A, Willis H J, Raykher A. et al . Long-term enteral nutrition facilitates optimization of body weight.  JPEN J Parenter Enteral Nutr. 2005;  29 198-203
    PubMedGoogle Scholar
  • 129 Miller D G, Ivey M, Young J. Home parenteral nutrition in treatment of severe radiation enteritis.  Ann Intern Med. 1979;  91 858-860
    PubMedGoogle Scholar
  • 130 Lavery I C, Steiger E, Fazio V W. Home parenteral nutrition in management of patients with severe radiation enteritis.  Dis Colon Rectum. 1980;  23 91-93
    CrossrefPubMedGoogle Scholar
  • 131 Lentz S S, Schray M F, Wilson T O. Chylous ascites after whole-abdomen irradiation for gynecologic malignancy.  Int J Rad Oncol Biol Phys. 1990;  19 435-438
    PubMedGoogle Scholar
  • 132 Silvain C, Besson I, Ingrand P. et al . Long-term outcome of severe radiation enteritis treated by total parenteral nutrition.  Dig Dis Sci. 1992;  37 1065-1071
    CrossrefPubMedGoogle Scholar
  • 133 McGeer A J, Detsky A S, O'Rourke K. Parenteral nutrition in cancer patients undergoing chemotherapy: a meta-analysis.  Nutrition. 1990;  6 233-240
    PubMedGoogle Scholar
  • 134 Cicco M De, Panarello G, Fantin D. et al . Parenteral nutrition in cancer patients receiving chemotherapy: effects on toxicity and nutritional status.  JPEN J Parenter Enteral Nutr. 1993;  17 513-518
    PubMedGoogle Scholar
  • 135 ASPEN Board of Directors and the Clinical Guidelines Task Force . Specific guidelines for disease - adults: cancer.  JPEN J Parenter Enteral Nutr. 2002;  26 82SA-83SA
    PubMedGoogle Scholar
  • 136 Bozzetti F, Mariani L, Bertinet D B. et al . Central venous catheter complications in 447 patients on home parenteral nutrition: an analysis of over 100 000 catheter days.  Clin Nutr. 2002;  21 475-485
    CrossrefPubMedGoogle Scholar
  • 137 Ireton-Jones C, DeLegge M. Home parenteral nutrition registry: a five-year retrospective evaluation of outcomes of patients receiving home parenteral nutrition support.  Nutrition. 2005;  21 156-160
    CrossrefPubMedGoogle Scholar
  • 138 Muscaritoli M, Grieco G, Capria S, Iori A P, Rossi F F. Nutritional and metabolic support in patients undergoing bone marrow transplantation.  Am J Clin Nutr. 2002;  75 183-190
    PubMedGoogle Scholar
  • 139 Herrmann V M, Petruska P J. Nutrition support in bone marrow transplant recipients.  Nutr Clin Pract. 1993;  8 19-27
    PubMedGoogle Scholar
  • 140 Szeluga D J, Stuart R K, Brookmeyer R, Utermohlen V, Santos G W. Nutritional support of bone marrow transplant recipients: a prospective, randomized clinical trial comparing total parenteral nutrition to an enteral feeding program.  Cancer Res. 1987;  47 3309-3316
    PubMedGoogle Scholar
  • 141 Raynard B, Nitenberg G, Gory-Delabaere G. et al . Summary of the Standards, Options and Recommendations for nutritional support in patients undergoing bone marrow transplantation (2002).  Br J Cancer. 2003;  89, Suppl 1 S101-S106
    CrossrefPubMedGoogle Scholar
  • 142 Muscaritoli M, Conversano L, Torelli G F. et al . Clinical and metabolic effects of different parenteral nutrition regimens in patients undergoing allogeneic bone marrow transplantation.  Transplantation. 1998;  66 610-616
    CrossrefPubMedGoogle Scholar
  • 143 Cetin T, Arpaci F, Dere Y. et al . Total parenteral nutrition delays platelet engraftment in patients who undergo autologous hematopoietic stem cell transplantation.  Nutrition. 2002;  18 599-603
    CrossrefPubMedGoogle Scholar
  • 144 Kajiume T, Yoshimi S, Kobayashi K, Kataoka N. Nutritional assessment of peripheral blood stem cell transplantation in children.  Pediatr Hematol Oncol. 2000;  17 389-392
    CrossrefPubMedGoogle Scholar
  • 145 Pedron C, Madero L, Madero R, Garcia-Novo M D, Diaz M A, Hernandez M. Short-term follow-up of the nutritional status of children undergoing autologous peripheral blood stem cell transplantation.  Pediatr Hematol Oncol. 2000;  17 559-566
    CrossrefPubMedGoogle Scholar
  • 146 Yokoyama S, Fujimoto T, Mitomi T, Yabe M, Yabe H, Kato S. Use of total parenteral nutrition in pediatric bone marrow transplantation.  Nutrition. 1989;  5 27-30
    PubMedGoogle Scholar
  • 147 Uderzo C, Rovelli A, Bonomi M, Fomia L, Pirovano L, Masera G. Total parenteral nutrition and nutritional assessment and leukaemic children undergoing bone marrow transplantation.  Eur J Cancer. 1991;  27 758-762
    PubMedGoogle Scholar
  • 148 Hopman G D, Pena E G, Cessie S Le, Weel M H Van, Vossen J M, Mearin M L. Tube feeding and bone marrow transplantation.  Med Pediatr Oncol. 2003;  40 375-379
    CrossrefPubMedGoogle Scholar
  • 149 Langdana A, Tully N, Molloy E, Bourke B, O'Meara A. Intensive enteral nutrition support in paediatric bone marrow transplantation.  Bone Marrow Transplant. 2001;  27 741-746
    CrossrefPubMedGoogle Scholar
  • 150 Ringwald-Smith K A, Heslop H E, Krance R A. et al . Energy expenditure in children undergoing hematopoietic stem cell transplantation.  Bone Marrow Transplant. 2002;  30 125-130
    CrossrefPubMedGoogle Scholar
  • 151 Duggan C, Bechard L, Donovan K. et al . Changes in resting energy expenditure among children undergoing allogeneic stem cell transplantation.  Am J Clin Nutr. 2003;  78 104-109
    PubMedGoogle Scholar
  • 152 Forchielli M L, Azzi N, Cadranel S, Paolucci G. Total parenteral nutrition in bone marrow transplant: what is the appropriate energy level?.  Oncology. 2003;  64 7-13
    CrossrefPubMedGoogle Scholar
  • 153 MacFie J. Ethical implications of recognizing nutritional support as a medical therapy.  Br J Surg. 1996;  83 1567-1568
    CrossrefPubMedGoogle Scholar
  • 154 Brozek J, Wells S, Keys A. Medical aspects of semistarvation in Leningrad (siege 1941 - 1942).  Am Rev Sov Med. 1946;  4 70-86
    PubMedGoogle Scholar
  • 155 Fliederbaum J. Clinical aspects of hunger disease in adults. In: Winnick M (ed) Hunger disease: Studies by the jewish physicians in the Warsaw ghetto. New York; John Wiley & Sons 1979: 11-43
    Google Scholar
  • 156 Winnick M. Hunger disease: Studies by the jewish physicians in the Warsaw ghetto. New York; John Wiley & Sons 1979
    Google Scholar
  • 157 Bundesärztekammer . Grundsätze der Bundesärztekammer zur ärztlichen Sterbebegleitung.  Deutsches Ärzteblatt. 1998;  95 B-1851-B-1853
    PubMedGoogle Scholar
  • 158 Winkler M F. Quality of life in adult home parenteral nutrition patients.  JPEN J Parenter Enteral Nutr. 2005;  29 162-170
    PubMedGoogle Scholar
  • 159 Bachmann P, Marti-Massoud C, Blanc-Vincent M P. et al . Standards, options and recommendations: nutritional support in palliative or terminal care of adult patients with progressive cancer.  Bull Cancer. 2001;  88 985-1006
    PubMedGoogle Scholar
  • 160 McKinlay A W. Nutritional support in patients with advanced cancer: permission to fall out?.  Proc Nutr Soc. 2004;  63 431-435
    CrossrefPubMedGoogle Scholar
  • 161 McCann R M, Hall W J, Groth-Juncker A. Comfort care for terminally ill patients. The appropriate use of nutrition and hydration.  JAMA. 1994;  272 1263-1266
    CrossrefPubMedGoogle Scholar
  • 162 Bruera E, Belzile M, Watanabe S, Fainsinger R L. Volume of hydration in terminal cancer patients.  Support Care Cancer. 1996;  4 147-150
    CrossrefPubMedGoogle Scholar
  • 163 Burge F. Dehydration symptoms of palliative care cancer patients.  J Pain Symptom Manage. 1993;  8 454-464
    CrossrefPubMedGoogle Scholar
  • 164 Ellershaw J E, Sutcliffe J M, Saunders C M. Dehydration and the dying patient.  J Pain Symptom Manage. 1995;  10 192-197
    CrossrefPubMedGoogle Scholar
  • 165 Musgrave C F, Opstad J. Fluid retention and intravenous hydration in the dying.  Palliat Med. 1996;  10 53
    PubMedGoogle Scholar
  • 166 Fainsinger R L, Bruera E. When to treat dehydration in a terminally ill patient?.  Support Care Cancer. 1997;  5 205-211
    CrossrefPubMedGoogle Scholar
  • 167 Michaud L, Burnand B, Stiefel F. Taking care of the terminally ill cancer patient: delirium as a symptom of terminal disease.  Ann Oncol. 2005;  15, Suppl 4 iv199-iv203
    PubMedGoogle Scholar
  • 168 Bruera E, Franco J J, Maltoni M, Watanabe S, Suarez-Almazor M. Changing pattern of agitated impaired mental status in patients with advanced cancer: association with cognitive monitoring, hydration, and opioid rotation.  J Pain Symptom Manage. 1995;  10 287-291
    CrossrefPubMedGoogle Scholar
  • 169 Stoutz N D de, Bruera E, Suarez-Almazor M. Opioid rotation for toxicity reduction in terminal cancer patients.  J Pain Symptom Manage. 1995;  10 378-384
    CrossrefPubMedGoogle Scholar
  • 170 Bruera E, Sala R, Rico M A. et al . Effects of parenteral hydration in terminally ill cancer patients: a preliminary study.  J Clin Oncol. 2005;  23 2366-2371
    CrossrefPubMedGoogle Scholar
  • 171 Bachmann P, Marti-Massoud C, Blanc-Vincent M P. et al . Summary version of the Standards, Options and Recommendations for palliative or terminal nutrition in adults with progressive cancer (2001).  Br J Cancer. 2003;  89, Suppl 1 S107-S110
    CrossrefPubMedGoogle Scholar